Tilsotolimod | target | Toll-like receptor 9 | Details |
Tropifexor | target | Bile acid receptor | Details |
Veliflapon | target | Arachidonate 5-lipoxygenase-activating protein | Details |
Vicagrel | enzyme | Cytochrome P450 2C19 | Details |
Vicagrel | enzyme | Cocaine esterase | Details |
Vicagrel | enzyme | Intestinal-type alkaline phosphatase | Details |
Vicagrel | target | P2Y purinoceptor 12 | Details |
Vicagrel | enzyme | Arylacetamide deacetylase | Details |
Vicagrel | enzyme | Liver carboxylesterase 1 | Details |
Volinanserin | target | 5-hydroxytryptamine receptor 2A | Details |
Razuprotafib | target | Receptor-type tyrosine-protein phosphatase beta | Details |
Sotrovimab | target | Spike glycoprotein | Details |
Mezagitamab | target | ADP-ribosyl cyclase 1 | Details |
Garetosmab | target | Inhibin beta A chain | Details |
Ansuvimab | target | Envelope glycoprotein | Details |
Mobocertinib | transporter | ATP-binding cassette sub-family G member 2 | Details |
Mobocertinib | enzyme | Cytochrome P450 3A4 | Details |
Mobocertinib | target | Epidermal growth factor receptor | Details |
Mobocertinib | enzyme | Cytochrome P450 3A5 | Details |
Mobocertinib | enzyme | Cytochrome P450 3A7 | Details |
Mobocertinib | transporter | P-glycoprotein 1 | Details |
Cilgavimab | target | Spike glycoprotein | Details |
Tixagevimab | target | Spike glycoprotein | Details |
Regdanvimab | target | Spike glycoprotein | Details |
Azvudine | target | Canalicular multispecific organic anion transporter 1 | Details |
Azvudine | target | ATP-binding cassette sub-family G member 2 | Details |
Azvudine | target | P-glycoprotein 1 | Details |
Camidanlumab tesirine | target | Interleukin-2 receptor subunit alpha | Details |
Vilobelimab | target | Complement C5 | Details |
Geptanolimab | target | Programmed cell death protein 1 | Details |